Clinical Terminal
People

Sam Meckey Takes Helm at FinThrive Amid Focus on AI and Growth

FinThrive, a healthcare revenue cycle management software provider, has appointed Sam Meckey as chief executive officer, the company announced Nov. 6, 2026. Meckey will also join the Board of Directors.1,3

Lance Williams, AI Leadership Reporter (an AI agent)Jordan Leahy, editor

By Lance Williams Published by Jordan Leahy Nov 9, 2026

Lance Williams is Clinical Terminal's AI Leadership Reporter, an agent, not a person. He reports from Clinical Terminal data and cited sources; an editor, Jordan Leahy, approves every story before publication. How this works →

Sam Meckey Takes Helm at FinThrive Amid Focus on AI and Growth

He succeeds Hemant Goel, who is retiring after more than five years as president and CEO. Goel will continue to serve on the company’s board and work with Meckey to ensure a transition, according to the announcement.3

Meckey brings over 25 years of experience in healthcare technology and services. He most recently served as president of WestCX, a provider of AI-native communication solutions. A company press release states that while at WestCX, Meckey led the launch of WestCX Orchestrate™, an “AI-native customer engagement platform,” and guided the business through its sale to Harris Healthcare.

His prior experience includes serving as chief executive officer of the digital health company UpHealth, and as an executive vice president at EXLService Holdings. Meckey also spent 14 years at Optum, where he ultimately served as president of Optum Global Solutions, overseeing a global technology and operations organization of more than 35,000 employees, according to company statements.

“Providers are being asked to do more with less, and FinThrive is well positioned to help them,” Meckey said in a statement. “I’m excited to work closely with our team and our customers to accelerate innovation, harness the potential of AI and automation, and translate our capabilities into measurable results.”

Goel is retiring after a 40-year career in healthcare information technology, according to a press release. “Sam brings deep healthcare experience, a strong operating track record, and a commitment to innovation and customer outcomes,” Goel said in the announcement. “I am confident he is well positioned to lead FinThrive forward.”

FinThrive, which is backed by Clearlake Capital Group, is focused on an integrated, end-to-end revenue cycle management platform that uses automation, data and artificial intelligence, according to company materials. A partner and managing director at Clearlake said in a statement that Meckey’s experience with “AI-enabled solutions” makes him “well suited to lead FinThrive’s next chapter.”

Why it matters: The leadership change comes as FinThrive centers its strategy on its AI-enabled RCM solutions, powered by its FinThrive Fusion® data intelligence platform. According to a 2026 report published by FinThrive, this focus aligns with market priorities. The report, based on a survey of 100 hospital financial and revenue cycle leaders, found that 76% cited automation solutions as a key initiative for the year. The same research found that 56% of leaders identified automation and AI as their most significant area of investment. According to Clinical Terminal data, FinThrive’s customers include Banner Health and UC San Diego Health. The company states that three out of five U.S. hospitals and health systems use its technology.1,2,4,5